This is the first publication outlining the scientific strategy of the Global Vaccine Enterprise, the most ambitious vaccine research programme ever undertaken with the goal of overcoming the enormous scientific and other challenges in the development of an HIV vaccine. Among the goals being set is the need for better coordination and transparency among researchers and organisations involved in HIV vaccine research, standardisation of laboratory and animal tests to enable different vaccine candidates to be compared and prioritised for further development, and the setting up of national research centres in countries of high HIV incidence, particularly in Africa, South America, India and the Caribbean.


Related topics